These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7556289)

  • 1. From hyperplasia to frank breast neoplasia. Carcinogenesis. Immunoprevention.
    Corocleanu M
    Eur J Gynaecol Oncol; 1995; 16(4):307-9. PubMed ID: 7556289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for preneoplasia immuno-detection and cancer immuno-prevention.
    Corocleanu M
    Eur J Gynaecol Oncol; 1992; 13(6):486-9. PubMed ID: 1473528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
    Vorherr H
    Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis for endometrial carcinoma carcinogenesis. Preventive prospects.
    Corocleanu M
    Clin Exp Obstet Gynecol; 1993; 20(4):254-8. PubMed ID: 8281709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign breast disease and the risk of breast cancer in the next 15 years.
    Socolov D; Anghelache I; Ilea C; Socolov R; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):135-40. PubMed ID: 25970956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is fibrocystic breast disease a pre-malignant state?
    Myhre E
    Acta Obstet Gynecol Scand Suppl; 1984; 123():189-91. PubMed ID: 6594011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal contraception and benign breast disease. Evaluation of a treatment protocol for chronic mastopathy with mastalgia].
    Leonardi M
    Minerva Ginecol; 1997 Jun; 49(6):271-6. PubMed ID: 9289667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project.
    Tobiassen T; Rasmussen T; Döberl A; Rannevik G
    Acta Obstet Gynecol Scand Suppl; 1984; 123():159-76. PubMed ID: 6594009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign proliferative disorders of the breast.
    Ahn HJ; Cho NH; Yang WI; Choi IJ
    Yonsei Med J; 1990 Jun; 31(2):168-73. PubMed ID: 2219974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of A and B tissue isoantigens in benign and malignant lesions of the breast.
    Strauchen JA; Bergman SM; Hanson TA
    Cancer; 1980 Apr; 45(8):2149-55. PubMed ID: 6245789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrocystic breast disease--breast cancer sequence].
    Habor V; Habor A; Copotoiu C; Panţîru A
    Chirurgia (Bucur); 2010; 105(2):191-4. PubMed ID: 20540231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of prostate-specific antigen in serum of women with fibroadenomas and breast cysts.
    Borchert GH; Giai M; Diamandis EP
    J Natl Cancer Inst; 1997 Apr; 89(8):587-8. PubMed ID: 9106652
    [No Abstract]   [Full Text] [Related]  

  • 13. [The relationship between benign breast proliferation (fibrocystic mastopathy) and the appearance of breast carcinoma].
    Alexa O; Stolnicu S; Horváth E; Jung J
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):101-9. PubMed ID: 12089936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast.
    Arthur JE; Ellis IO; Flowers C; Roebuck E; Elston CW; Blamey RW
    Br J Radiol; 1990 Nov; 63(755):845-9. PubMed ID: 2252976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast.
    Ingram DM; Nottage E; Roberts T
    Br J Cancer; 1991 Jul; 64(1):187-91. PubMed ID: 1854621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for breast cancer in women with proliferative breast disease.
    Dupont WD; Page DL
    N Engl J Med; 1985 Jan; 312(3):146-51. PubMed ID: 3965932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China.
    Li W; Ray RM; Lampe JW; Lin MG; Gao DL; Wu C; Nelson ZC; Fitzgibbons ED; Horner N; Hu YW; Shannon J; Satia JA; Patterson RE; Stalsberg H; Thomas DB
    Int J Cancer; 2005 Jul; 115(6):981-93. PubMed ID: 15723298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrocystic disease of the breast.
    Greenblatt RB; Samaras C; Vasquez JM; Nezhat C
    Clin Obstet Gynecol; 1982 Jun; 25(2):365-71. PubMed ID: 7105513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMPARISONS BETWEEN THE NON-PROLIFERATIVE AND PROLIFERATIVE THERAPY IN FIBROCYSTIC MASTOSIS.
    Carauleanu A; Socolov R; Rugina V; Gabia O; Carauleanu DM; Lupascu IA; Socolov D
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):321-7. PubMed ID: 27483712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.